Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 854 | 1,989 | 1,995 | 1,989 | 1,989 |
| Gross Profit | 854 | 1,989 | 1,995 | 1,989 | 1,989 |
| Operating Expenses | 14,165 | 13,593 | 10,969 | 9,581 | 9,764 |
| Operating Income | -13,311 | -11,604 | -8,974 | -7,592 | -7,775 |
| Interest Expense | 391 | 470 | 547 | 623 | 695 |
| Other Income | -1,623 | 293 | -5,052 | 1,038 | 863 |
| Pre-tax Income | -15,325 | -11,781 | -14,573 | -7,177 | -7,607 |
| Net Income Continuous | -15,325 | -11,781 | -14,573 | -7,177 | -7,607 |
| Net Income | $-15,325 | $-11,781 | $-14,573 | $-7,177 | $-7,607 |
| EPS Basic Total Ops | -52.49 | -41.99 | -54.59 | -25.20 | -31.50 |
| EPS Basic Continuous Ops | -53.14 | -41.06 | -54.34 | -27.52 | -30.90 |
| EPS Diluted Total Ops | -52.49 | -41.99 | -54.59 | -18.90 | -33.60 |
| EPS Diluted Continuous Ops | -53.14 | -39.97 | -54.34 | -29.46 | -29.98 |
| EBITDA(a) | $-13,221 | $-11,497 | $-8,853 | $-7,455 | $-7,623 |